Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border

Am J Trop Med Hyg. 1992 Jun;46(6):643-8. doi: 10.4269/ajtmh.1992.46.643.

Abstract

The Thai-Cambodian border is a difficult area in which to provide adequate malaria chemoprophylaxis because of multiple drug-resistant Plasmodium falciparum. In 1990-1991, Thai soldiers were randomly selected to receive proguanil (200 mg/day) combined with dapsone (4 mg or 12.5 mg/day) (n = 184) or pyrimethamine/dapsone (12.5 mg and 100 mg/week) (n = 177). Doxycycline (100 mg/day) was given to men with glucose-6-phosphate dehydrogenase deficiency (n = 77). Falciparum malaria attack rates were the same whether proguanil/dapsone (10.3%) or pyrimethamine/dapsone (11.3%) was used. However, proguanil/dapsone was more effective than pyrimethamine/dapsone in preventing vivax malaria (1.6% versus 12.4%). Men receiving doxycycline had falciparum malaria (3.9%) and vivax malaria (1.3%) at low rates. Adjusting the dapsone component from 4 mg to 12.5 mg did not improve the prophylactic effectiveness. Hematologic toxicity was not observed with the proguanil/dapsone combination. We conclude that proguanil/dapsone is not a useful alternative for malaria chemoprophylaxis on the Thai-Cambodian border.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Blood Cells / drug effects
  • Cambodia
  • Dapsone / adverse effects
  • Dapsone / therapeutic use*
  • Doxycycline / therapeutic use
  • Drug Therapy, Combination
  • Drug Tolerance
  • Glucosephosphate Dehydrogenase Deficiency / complications
  • Humans
  • Leukocyte Count / drug effects
  • Malaria, Falciparum / prevention & control*
  • Malaria, Vivax / prevention & control*
  • Male
  • Military Personnel
  • Patient Compliance
  • Proguanil / adverse effects
  • Proguanil / therapeutic use*
  • Pyrimethamine / therapeutic use
  • Thailand

Substances

  • Dapsone
  • Doxycycline
  • Proguanil
  • Pyrimethamine